# Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia

> **NCT01049113** · PHASE1 · TERMINATED · sponsor: **Traws Pharma, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Lymphoma
- Acute Lymphocytic Leukemia

## Interventions

- **DRUG:** ON 013105

## Key facts

- **NCT ID:** NCT01049113
- **Lead sponsor:** Traws Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of available clinical drug supply
- **Last updated:** 2015-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049113, "Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01049113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*